Early B cell development and B cell maturation are impaired in patients with active hemophagocytic lymphohistiocytosis
Jenny Shim, Sunita Park, Suresh Venkateswaran, Deepak Kumar, Chengyu Prince, Vaunita Cohen Parihar, Larkin Maples, Edmund K. Waller, Subra Kugathasan, Michael Briones, Miyoung Lee, Curtis Henry, Sampath Prahalad, Shanmuganathan Chandrakasan- Cell Biology
- Hematology
- Immunology
- Biochemistry
Hemophagocytic lymphohistiocytosis (HLH) is characterized by hyperinflammation and multi-organ dysfunction. Infections, including the reactivation of viruses, contribute to significant disease mortality in HLH. While T and NK cell-driven immune activation and dysregulation are well described, limited data exist on the status of the B cell compartment and humoral immune function in HLH. We noted marked suppression of early B cell development in patients with active HLH. In vitro B cell differentiation studies following exposure to HLH-defining cytokines, such as interferon-gamma (IFN-g) and tumor necrosis factor, recapitulated B cell development arrest. mRNA sequencing of human CD34+ cells exposed to IFN-g demonstrated changes in genes and pathways affecting B cell development and maturation. In addition, patients with active HLH exhibited a marked decrease in class-switched memory B (CSMB) cells and a decrease in bone marrow plasmablast/plasma cell compartments. The decrease in CSMB cells was associated with a decrease in circulating T follicular helper (cTfh) cells. Finally, lymph node and spleen evaluation in a patient with HLH revealed absent germinal center formation and hemophagocytosis with associated lymphopenia. Reassuringly, the frequency of CSMB and cTfh improved with control of T cell activation. Taken together, in patients with active HLH, these changes in B cells may affect the humoral immune response; however, further immune studies are needed to determine its clinical significance.